FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2017. The put-call ratio across all filers is 21.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $78,000 | +20.0% | 14,000 | 0.0% | 0.01% | +11.1% |
| Q2 2017 | $65,000 | -5.8% | 14,000 | 0.0% | 0.01% | -10.0% |
| Q1 2017 | $69,000 | -55.5% | 14,000 | 0.0% | 0.01% | -58.3% |
| Q4 2016 | $155,000 | +20.2% | 14,000 | 0.0% | 0.02% | +20.0% |
| Q3 2016 | $129,000 | +44.9% | 14,000 | 0.0% | 0.02% | +33.3% |
| Q2 2016 | $89,000 | -2.2% | 14,000 | 0.0% | 0.02% | -6.2% |
| Q1 2016 | $91,000 | -20.2% | 14,000 | 0.0% | 0.02% | -20.0% |
| Q4 2015 | $114,000 | +10.7% | 14,000 | 0.0% | 0.02% | +5.3% |
| Q3 2015 | $103,000 | -28.5% | 14,000 | 0.0% | 0.02% | -24.0% |
| Q2 2015 | $144,000 | +11.6% | 14,000 | 0.0% | 0.02% | +8.7% |
| Q1 2015 | $129,000 | – | 14,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $28,738,000 | 4.90% |
| DSC Advisors, L.P. | 1,187,604 | $7,138,000 | 4.14% |
| Opaleye Management Inc. | 960,000 | $5,769,000 | 1.85% |
| DAFNA Capital Management LLC | 352,741 | $2,120,000 | 1.14% |
| Vivo Capital, LLC | 855,000 | $5,139,000 | 1.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 382,838 | $2,301,000 | 0.81% |
| SENZAR ASSET MANAGEMENT, LLC | 377,397 | $2,268,000 | 0.58% |
| Sio Capital Management, LLC | 131,200 | $789,000 | 0.44% |
| Perceptive Advisors | 1,117,324 | $6,715,000 | 0.22% |
| Tekla Capital Management LLC | 930,398 | $5,592,000 | 0.22% |